Winston Financial Statements From 2010 to 2026

WPHM Stock  USD 0.0003  0.00  0.00%   
Winston Pharmaceuticals' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Winston Pharmaceuticals' valuation are provided below:
Gross Profit
-472 K
Profit Margin
(1.70)
Market Capitalization
23.2 K
Enterprise Value Revenue
0.0986
Revenue
1.4 M
There are over one hundred fourteen available fundamental gauges for Winston Pharmaceuticals, which can be analyzed over time and compared to other ratios. Self-guided Investors are advised to confirm Winston Pharmaceuticals' prevalent fundamentals against the trend between 2010 and 2026 to make sure the company can sustain itself down the road. As of the 28th of January 2026, Market Cap is likely to grow to about 5.2 M. Also, Enterprise Value is likely to grow to about 3.7 M

Winston Pharmaceuticals Total Revenue

1.68 Million

Check Winston Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Winston Pharmaceuticals' main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Interest Expense of 0.0 or Selling General Administrative of 1.5 M, as well as many indicators such as Price To Sales Ratio of 8.02, Dividend Yield of 0.0 or PTB Ratio of 10.66. Winston financial statements analysis is a perfect complement when working with Winston Pharmaceuticals Valuation or Volatility modules.
  
Build AI portfolio with Winston Stock
Check out the analysis of Winston Pharmaceuticals Correlation against competitors.
To learn how to invest in Winston Stock, please use our How to Invest in Winston Pharmaceuticals guide.

Winston Pharmaceuticals Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets3.2 M1.9 M1.7 M
Slightly volatile
Total Current Liabilities1.1 M1.4 M1.1 M
Slightly volatile
Total Stockholder Equity964.4 K561.9 K556.9 K
Very volatile
Net Tangible Assets944.5 K541.8 K540.2 K
Very volatile
Accounts Payable560.6 K832.8 K678.4 K
Slightly volatile
Cash3.1 M1.8 M1.6 M
Slightly volatile
Net Receivables49.2 K34.2 K41.4 K
Slightly volatile
Total Liabilities1.2 M1.4 M1.1 M
Slightly volatile
Total Current Assets3.2 M1.9 M1.7 M
Slightly volatile
Intangible Assets18 K15.7 K18 K
Slightly volatile
Common Stock50.3 K89 K73 K
Pretty Stable
Property Plant Equipment15.6 K15.8 K14.1 K
Slightly volatile

Winston Pharmaceuticals Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative1.5 M2.4 M1.9 M
Slightly volatile
Total Other Income Expense Net45.8 K77.3 K80 K
Very volatile

Winston Pharmaceuticals Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation8.3 K8.1 K8.9 K
Slightly volatile
Capital Expenditures6316641.5 K
Slightly volatile
Change To Account Receivables21.2 K20.2 K17.5 K
Slightly volatile
Total Cash From Financing Activities114.9 K121 K199.1 K
Slightly volatile
Change To Netincome113.7 K108.3 K91.5 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio8.024.554.6201
Pretty Stable
Days Sales Outstanding10.8811.4512.1542
Slightly volatile
Average Payables70.2 K79 K86.3 K
Slightly volatile
Capex To Depreciation0.120.130.2184
Slightly volatile
Payables Turnover0.01360.01430.0363
Slightly volatile
Sales General And Administrative To Revenue1.181.331.4535
Slightly volatile
Research And Ddevelopement To Revenue1.621.71.8679
Slightly volatile
Capex To Revenue8.0E-48.0E-40.0028
Slightly volatile
Cash Per Share0.02790.02930.0244
Slightly volatile
Days Payables Outstanding15 K26.4 K26.7 K
Pretty Stable
Income Quality1.491.421.4829
Slightly volatile
Intangibles To Total Assets0.00510.00940.0097
Very volatile
Current Ratio1.941.251.3284
Slightly volatile
Receivables Turnover17.9132.9933.6577
Very volatile
Capex Per Share0.00.00.0
Slightly volatile
Average Receivables37 K54.2 K56.9 K
Very volatile
Revenue Per Share0.01250.02050.0212
Very volatile
Interest Debt Per Share0.30.430.4533
Very volatile
Debt To Assets16.3518.420.0808
Slightly volatile
Operating Cycle10.8811.4512.1542
Slightly volatile
Days Of Payables Outstanding15 K26.4 K26.7 K
Pretty Stable
Ebt Per Ebit1.081.110.9843
Slightly volatile
Quick Ratio1.941.251.3284
Slightly volatile
Cash Ratio1.91.181.2651
Slightly volatile
Days Of Sales Outstanding10.8811.4512.1542
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.11.151.0152
Slightly volatile
Fixed Asset Turnover50.1691.2293.1961
Very volatile
Debt Ratio16.3518.420.0808
Slightly volatile
Price Sales Ratio8.024.554.6201
Pretty Stable
Asset Turnover0.790.750.7804
Slightly volatile
Gross Profit Margin0.790.890.9747
Slightly volatile

Winston Pharmaceuticals Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap5.2 MM5.1 M
Slightly volatile
Enterprise Value3.7 M3.6 M3.7 M
Slightly volatile

About Winston Pharmaceuticals Financial Statements

Winston Pharmaceuticals investors utilize fundamental indicators, such as revenue or net income, to predict how Winston Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Total Revenue1.6 M1.7 M
Cost Of Revenue2.4 M1.9 M
Sales General And Administrative To Revenue 1.33  1.18 
Research And Ddevelopement To Revenue 1.70  1.62 
Revenue Per Share 0.02  0.01 
Ebit Per Revenue(1.77)(1.86)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Winston Pharmaceuticals is a strong investment it is important to analyze Winston Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Winston Pharmaceuticals' future performance. For an informed investment choice regarding Winston Stock, refer to the following important reports:
Check out the analysis of Winston Pharmaceuticals Correlation against competitors.
To learn how to invest in Winston Stock, please use our How to Invest in Winston Pharmaceuticals guide.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Is Drug Manufacturers - Specialty & Generic space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Winston Pharmaceuticals. If investors know Winston will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Winston Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share
0.021
Quarterly Revenue Growth
(0.07)
Return On Assets
(0.59)
Return On Equity
(2.05)
The market value of Winston Pharmaceuticals is measured differently than its book value, which is the value of Winston that is recorded on the company's balance sheet. Investors also form their own opinion of Winston Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Winston Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Winston Pharmaceuticals' market value can be influenced by many factors that don't directly affect Winston Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Winston Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Winston Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Winston Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.